Theacrine

Supplements · Nootropics · Supplement, Typed Supps

A caffeine cousin sold as the kinder stimulant — the “no crash” claim is still thin.

Stage by stage

Intake (Capsule): Absorbed in the small intestine.
Small intestine (Absorbed): Absorbed alongside standard digestion.
Bloodstream (Crosses into the brain): Crosses into the brain after absorption.
Alertness pathways (Caffeine-adjacent mechanism): Works through pathways related to those caffeine uses, with a claimed slower tolerance buildup still under-studied independently.

What the evidence supports

Increasing subjective energy, focus and motivation — limited evidence. Small acute human trials report increased energy and focus, but sample sizes are tiny and the compound is understudied compared with caffeine.
Not building tolerance the way caffeine does — limited evidence. One 8-week study at up to 300 mg/day found no habituation, but this rests on a single controlled trial.
Evidence on Safety beyond eight weeks — insufficient evidence. The longest controlled study ran eight weeks, so longer-term use is untested.

Typical dose

100–300 mg/day (single doses around 200 mg have been studied)

Upper limit: No established UL

Timing

Morning or early afternoon, similar to caffeine.

Time to effect

30–60 min: Noticeable effect.

Medication interactions

Caffeine and other stimulants: Additive stimulant effect; theacrine can also raise caffeine exposure by slowing its clearance. (moderate)

Common myth

“Theacrine definitively avoids the tolerance problems of caffeine.” In reality: The tolerance-resistance claim comes mostly from manufacturer-funded research — independent, long-term evidence is still limited.